Multicenter Randomized Open-Label Phase II Clinical Study Comparing Outcomes of NK105 and Paclitaxel in Advanced or Recurrent Breast Cancer

BACKGROUND: NK105 is a paclitaxel (PTX)-incorporating “core-shell-type” polymeric micellar nanoparticle formulation composed of block copolymers (polyethylene glycol and a polyamino acid). The efficacy and safety of NK105 and paclitaxel in advanced or recurrent breast cancer have never been compared...

Descripción completa

Detalles Bibliográficos
Autores principales: Kosaka, Yoshimasa, Saeki, Toshiaki, Takano, Toshimi, Aruga, Tomoyuki, Yamashita, Toshinari, Masuda, Norikazu, Koibuchi, Yukio, Osaki, Akihiko, Watanabe, Junichiro, Suzuki, Ryu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547548/
https://www.ncbi.nlm.nih.gov/pubmed/36217496
http://dx.doi.org/10.2147/IJN.S372477

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547548/
https://www.ncbi.nlm.nih.gov/pubmed/36217496
http://dx.doi.org/10.2147/IJN.S372477

Ejemplares similares